We are live on ! Find out more
VCG

Vantage Consulting Group Portfolio holdings

AUM $19.7M
1-Year Est. Return 280.87%
This Fund
S&P 500
This Quarter Est. Return
-7.33%
1 Year Est. Return
+280.87%
3 Year Est. Return
+261.08%
5 Year Est. Return
+180.34%
10 Year Est. Return
AUM
$467M
AUM Growth
-$108M
Cap. Flow
-$59.1M
Cap. Flow %
-12.66%
Top 10 Hldgs %
86.62%
Holding
221
New
10
Increased
113
Reduced
80
Closed
15

Sector Composition

Rank Sector Weight
1 Healthcare 75.53%
2 Consumer Staples 2.42%
3 Technology 2.33%
4 Consumer Discretionary 2.01%
5 Energy 1.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AEP icon
151
American Electric Power
AEP
$69.6B
$237K 0.05%
2,917
-92
-3% -$8.03K
INCY icon
152
Incyte
INCY
$24.2B
$236K 0.05%
3,434
+676
+25% +$51.4K
JNJ icon
153
Johnson & Johnson
JNJ
$618B
$236K 0.05%
1,459
+89
+6% +$15.2K
TPR icon
154
Tapestry
TPR
$30.8B
$236K 0.05%
6,374
+621
+11% +$25.6K
NFLX icon
155
Netflix
NFLX
$299B
$235K 0.05%
3,850
-810
-17% -$44.6K
LLY icon
156
Eli Lilly
LLY
$1.02T
$234K 0.05%
1,014
+6
+0.6% +$1.48K
OGN icon
157
Organon & Co
OGN
$3.56B
$234K 0.05%
7,150
-478
-6% -$15.3K
VRTX icon
158
Vertex Pharmaceuticals
VRTX
$121B
$234K 0.05%
1,292
+115
+10% +$22.5K
CTLT
159
DELISTED
CATALENT, INC.
CTLT
$234K 0.05%
1,759
-315
-15% -$39.3K
BIIB icon
160
Biogen
BIIB
$30B
$230K 0.05%
813
+235
+41% +$77K
ETR icon
161
Entergy
ETR
$50.2B
$230K 0.05%
4,640
-50
-1% -$2.68K
PFE icon
162
Pfizer
PFE
$143B
$230K 0.05%
5,347
-285
-5% -$12.6K
CMA
163
DELISTED
Comerica
CMA
$229K 0.05%
+2,840
New +$204K
NKE icon
164
Nike
NKE
$61.9B
$229K 0.05%
1,578
-361
-19% -$58.9K
BMY icon
165
Bristol-Myers Squibb
BMY
$133B
$228K 0.05%
3,852
+486
+14% +$32K
ZTS icon
166
Zoetis
ZTS
$32.4B
$228K 0.05%
1,175
-67
-5% -$13.5K
SIVB
167
DELISTED
SVB Financial Group
SIVB
$228K 0.05%
352
-7
-2% -$4.06K
CAG icon
168
Conagra Brands
CAG
$6.94B
$227K 0.05%
6,714
+867
+15% +$29.3K
GIS icon
169
General Mills
GIS
$19.1B
$227K 0.05%
3,799
+310
+9% +$18.3K
REGN icon
170
Regeneron Pharmaceuticals
REGN
$78.5B
$227K 0.05%
375
-49
-12% -$30.4K
PBCT
171
DELISTED
People's United Financial Inc
PBCT
$226K 0.05%
12,913
+1,762
+16% +$28.6K
KHC icon
172
Kraft Heinz
KHC
$30.7B
$225K 0.05%
6,106
+1,080
+21% +$40.7K
LW icon
173
Lamb Weston
LW
$7.22B
$225K 0.05%
3,660
+1,055
+40% +$71.4K
AVGO icon
174
Broadcom
AVGO
$1.85T
$223K 0.05%
4,600
-210
-4% -$10.2K
CPRT icon
175
Copart
CPRT
$27B
$222K 0.05%
6,392
-888
-12% -$31.7K

Similar funds

Vantage Consulting Group's Q3 2021 Portfolio in Review

As of Q3 2021, Vantage Consulting Group held 221 positions worth $467M, down 19% from $575M the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Vantage Consulting Group withdrew a net $59.1M in Q3 2021, closing 15 positions and reducing 80 holdings. Its most notable exit was Alphabet (Google) Class C, an estimated $253K position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 76% of assets, down from 79% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, Vantage Consulting Group opened a new position in Match Group worth $329K.

  • Vantage Consulting Group's largest Q3 2021 buy was Match Group: 2,095 shares worth $329K.
  • Vantage Consulting Group added most to Syntax Stratified MidCap ETF in Q3 2021, an estimated $206K increase.
  • Vantage Consulting Group's biggest Q3 2021 reduction was Royalty Pharma, cutting an estimated $56M.
  • Vantage Consulting Group fully exited Alphabet (Google) Class C in Q3 2021, selling an estimated $253K.
  • Vantage Consulting Group's ten largest holdings make up 87% of its $467M portfolio in Q3 2021.
  • Vantage Consulting Group opened 10 new positions and closed 15 in Q3 2021.
  • Vantage Consulting Group's portfolio value fell 19% quarter-over-quarter to $467M.

Based on Vantage Consulting Group's 13F filing for Q3 2021, filed 10 Nov 2021.